Amgen has partnered with the American Heart Association on Check. Change. Control. CholesterolTM, which aims to reduce the number of Americans who have heart attacks and strokes by improving cholesterol management of patients with high-risk cardiovascular disease through a multifaceted approach.
Amgen has partnered with the American College of Cardiology (ACC) on TRANSFORM: ACS, a program that aims to initiate lipid-lowering treatment closer to hospital discharge for patients with acute coronary syndrome (ACS).
Amgen is part of the CDC Foundation's Alliance for the Million Hearts campaign, an initiative focused on changing the way people think about and embrace cardiovascular disease prevention – promoting simple and sustained steps that people can take to help protect their heart health.
Amgen is supporting sponsor of the Cardiometabolic Center Alliance (CMCA) founded by Saint Luke's Mid America Heart Institute. The CMCA seeks to establish Cardiometabolic Centers of Excellence nationwide, aimed at transforming the treatment and improving the lives of those living with cardiovascular disease and diabetes.
Amgen joined the CardioHealth Alliance to expedite evidence-based solutions for prevention and care of cardiovascular, renal, and cardiometabolic diseases. The CardioHealth Alliance brings together a multidisciplinary group of experts to improve disease care pathways and expedite the implementation of evidence into practice.
The content referenced above is provided by independent, non-profit organizations that may provide useful information and resources. Amgen has no control over these programs and provides information as a courtesy only.